- Report
- August 2024
- 96 Pages
China
From €1777EUR$1,800USD£1,484GBP
- Report
- August 2024
- 233 Pages
China
From €3950EUR$4,000USD£3,298GBP
- Report
- August 2024
- 90 Pages
China
From €1777EUR$1,800USD£1,484GBP
- Report
- July 2024
- 132 Pages
Global
From €938EUR$950USD£783GBP
- Report
- July 2024
- 132 Pages
Global
From €938EUR$950USD£783GBP
- Report
- July 2024
- 132 Pages
Global
From €938EUR$950USD£783GBP
- Report
- July 2024
- 132 Pages
Global
From €938EUR$950USD£783GBP
- Report
- July 2024
- 132 Pages
Global
From €938EUR$950USD£783GBP
- Report
- July 2024
- 132 Pages
Global
From €938EUR$950USD£783GBP
- Report
- July 2024
- 132 Pages
Global
From €938EUR$950USD£783GBP
- Report
- July 2024
- 132 Pages
Global
From €938EUR$950USD£783GBP
- Report
- July 2024
- 132 Pages
Global
From €938EUR$950USD£783GBP
- Report
- July 2024
- 132 Pages
Global
From €938EUR$950USD£783GBP
- Report
- July 2024
- 132 Pages
Global
From €938EUR$950USD£783GBP
- Report
- July 2024
- 82 Pages
China
From €1777EUR$1,800USD£1,484GBP
- Report
- July 2024
- 99 Pages
China
From €1777EUR$1,800USD£1,484GBP
- Report
- June 2024
- 70 Pages
United States
From €938EUR$950USD£783GBP
- Report
- June 2024
- 70 Pages
United Kingdom
From €938EUR$950USD£783GBP
The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more